# Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors

> **NCT00116896** · PHASE1 · COMPLETED · sponsor: **OSI Pharmaceuticals** · enrollment: 25 (—)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** OSI-7904L
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT00116896
- **Lead sponsor:** OSI Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 25 (—)
- **Last updated:** 2009-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00116896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00116896, "Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00116896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*